Matching articles for "pyridoxine"
Issue 1753 · April 27, 2026 Free
In Brief: New Warnings for Carbidopa/Levodopa Products

The FDA has required that the labels of all carbidopa/levodopa-containing products (Crexont, Dhivy, Duopa, Rytary, Sinemet, Sinemet CR, Stalevo, Vyalev) include a warning about the risk of vitamin B6…

Med Lett Drugs Ther. 2026 Apr 27; 68(1753):72 doi:10.58347/tml.2026.1753b
The FDA has required that the labels of all carbidopa/levodopa-containing products (Crexont, Dhivy, Duopa, Rytary, Sinemet, Sinemet CR, Stalevo, Vyalev) include a warning about the risk of vitamin B6 (pyridoxine) deficiency and vitamin B6 deficiency-related seizures associated with their use. The combination of carbidopa/levodopa is the most effective treatment for the motor symptoms of Parkinson's disease and recent evidence favors its early use.
Issue 1422 · August 5, 2013
Diclegis for Nausea and Vomiting of Pregnancy

The FDA has approved Diclegis (Duchesnay) , a fixed-dose, delayed-release combination of the H 1 -antihistamine doxylamine and the vitamin B 6 analog pyridoxine, for treatment of nausea and vomiting of…

Med Lett Drugs Ther. 2013 Aug 5; 55(1422):61-2
The FDA has approved Diclegis (Duchesnay) , a fixed-dose, delayed-release combination of the H 1 -antihistamine doxylamine and the vitamin B 6 analog pyridoxine, for treatment of nausea and vomiting of pregnancy in women who do not respond to conservative management. It is only available by prescription. Doxylamine and pyridoxine, both currently available over the counter, were previously available by prescription in a fixed-dose combination (Bendectin) for morning sickness. Bendectin was voluntarily withdrawn in the US in 1983 because of claims of teratogenicity that have since been disproven. The combination has continued to be available in Canada as Diclectin .
Issue 1213 · July 18, 2005
Vitamin Supplements

Many patients ask their physicians whether they should take vitamins. Since the last Medical Letter article on this subject, more data have become available on the benefits and risks of taking vitamin…

Med Lett Drugs Ther. 2005 Jul 18; 47(1213):57-8
Many patients ask their physicians whether they should take vitamins. Since the last Medical Letter article on this subject, more data have become available on the benefits and risks of taking vitamin supplements.
Issue 1168 · October 27, 2003
Lowering Plasma Homocysteine

High plasma homocysteine concentrations, like high cholesterol, have been associated with an increased risk of cardiovascular disease and death (O Nygσrd et al, N Engl J Med 1997; 337:230; RS Vasan et al,…

Med Lett Drugs Ther. 2003 Oct 27; 45(1168):85-6
High plasma homocysteine concentrations, like high cholesterol, have been associated with an increased risk of cardiovascular disease and death (O Nygσrd et al, N Engl J Med 1997; 337:230; RS Vasan et al, JAMA 2003; 289:1251). In one meta-analysis, 25% lower plasma homocysteine concentrations were associated with 11% less coronary heart disease and 19% less stroke (Homocysteine Studies Collaboration, JAMA 2002; 288:2015). Should we be trying to lower serum homocysteine concentrations in our patients?
Issue 1032 · July 31, 1998
Vitamin Supplements

Many patients ask their physicians whether they should take vitamins. In recent years, more data have become available on the risks and benefits of taking vitamin supplements.

Med Lett Drugs Ther. 1998 Jul 31; 40(1032):75-7
Many patients ask their physicians whether they should take vitamins. In recent years, more data have become available on the risks and benefits of taking vitamin supplements.
Issue 763 · April 8, 1988
Drugs for Tuberculosis

After many years of decline, the incidence of tuberculosis has recently increased because the disease occurs in patients with AIDS (Morbid Mortal Weekly Rep, 36:817, Jan 1, 1988). For uncomplicated…

Med Lett Drugs Ther. 1988 Apr 8; 30(763):43-4
After many years of decline, the incidence of tuberculosis has recently increased because the disease occurs in patients with AIDS (Morbid Mortal Weekly Rep, 36:817, Jan 1, 1988). For uncomplicated tuberculosis, the recent trend in tuberculosis treatment has been toward a shorter period of therapy and increased use of pyrazinamide.